Pharma Faces: Taher Hassen, Merck Morocco
Taher Hassen has been in position as GM for Morocco and Tunisia at Merck for four years, overseeing year-on-year double-digit growth for the affiliate ever since. His current priorities include…
Patrick is the managing editor of PharmaBoardroom
Taher Hassen has been in position as GM for Morocco and Tunisia at Merck for four years, overseeing year-on-year double-digit growth for the affiliate ever since. His current priorities include…
Iberma, one of the leading domestic pharma manufacturers in Morocco, has evolved significantly since its founding in 1994 to become the market leader in several therapeutic areas. The company also…
Jorge Alderete, president of ALK Americas, recently spoke to PharmaBoardroom about his 20+ years with the Danish mid-cap, the challenges in communicating the USA’s challenging market access environment to a…
Four Belgium country managers for some of the world’s largest pharma companies give their words of wisdom for women starting out in the industry. “Focus on your strengths” Sonja…
Carol Lynch, president of Sandoz US and head of Sandoz North America, recently spoke exclusively to PharmaBoardroom about how her diverse global experiences in innovative biopharma and biosimilars are informing…
Alphamab Oncology and I-Mab Biopharma, two of China’s fastest-growing biotech firms, both bolstered by recent successful IPOs, are increasingly adapting their portfolio strategies to launch products on the large but…
Two years on from the introduction of Novartis Oncology’s CAR-T therapy to Europe, Emnuele Ostuni, the firm’s European head of cell and gene therapy, spoke to PharmaBoardroom about the pioneering…
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are working together to develop a vaccine for the novel coronavirus (COVID-19);…
PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Czech Republic is available for download now. Home to a USD 3.38 billion pharma market, one of Central and Eastern Europe’s…
With the global coronavirus pandemic still ongoing and teleworking having become the new normal, pharma executives from across the world are giving us their insights into how they are managing…
Indian firm Biocon has seen great success in the US in recent years, with two biosimilar launches and a range of generic medicines now available on the American market. …
PharmaBoardroom’s latest country report gives an up-to-date and comprehensive overview of one of the most strategic and innovation-friendly nations on earth: The UAE. The UAE’s pharma market was predicted…
See our Cookie Privacy Policy Here
